The most detailed study to date on the mechanisms by which a common type of bacterium, Staphylococcus aureus, adapts to living on the human body could help improve the prevention, diagnosis, and ...
Urinary tract infections (UTIs) are recognized as the second most common medical condition, following respiratory infections. Despite the availability of numerous efficacious antibiotics for the ...
HY-133 is under clinical development by HyPharm and currently in Phase I for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. According to GlobalData, Phase I drugs for ...